Vaxcyte PCVX
NASDAQ PCVX
$66.23 +2.55 (+4.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Receivables - Net (2021)

Updated

Vaxcyte's Receivables - Net was $5 million in Q3 2021.

Analysis

Vaxcyte (PCVX) Receivables - Net (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Vaxcyte 9.60 Bn 3.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 5.00 Mn
API Access

Vaxcyte Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=PCVX&period=max&api_key=YOUR_API_KEY